Previous 10 | Next 10 |
2024-03-10 13:00:53 ET More on the markets S&P 500: Time To Hedge, Here's How How The S&P 500 Could Actually Be Closer To 4,200 Than 5,000 SPDR S&P 500 ETF And Invesco QQQ Trust: Almost All Investors Are Crowded Into The Same Side Of The Boat Cata...
Results From a Large-Scale Prospective Study Investigating Long-Term Anti-Estrogen Therapy Recommendations Published in JNCCN — Journal of the National Comprehensive Cancer Network Hologic, Inc. (Nasdaq: HOLX) and its subsidiary, Biotheranostics, Inc., today announced newly publi...
Global Leader in Women’s Health to Present Research and Educational Opportunities Focused on Improving Workflow and Efficiency Hologic, Inc. (Nasdaq: HOLX) continues to deliver on its commitment to advancing women’s health by unveiling new research in artificial intelligen...
2024-02-11 10:54:53 ET Summary Hologic aims to elevate women's health globally, with diagnostics making up nearly half of sales. The company experienced a boom in COVID diagnostics sales in 2020 and 2021, creating headwinds thereafter, yet this is set to end in 2024. Amidst a ...
2024-02-06 13:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-02-02 07:04:51 ET The financials of the company show a decreasing trend in revenue growth due to lower spare parts sales and a decrease in service contracts. However, there was an increase in installation and training revenue. Operating expenses decreased due to various factors, but ther...
2024-02-02 05:57:43 ET Hologic ( NASDAQ: HOLX ) has received approval from the U.S. Food and Drug Administration (FDA) approval for its new digital cytology system, making it the first FDA-cleared digital cytology platform.... Read the full article on Seeking Alpha ...
2024-02-01 22:56:03 ET Hologic, Inc. (HOLX) Q1 2024 Earnings Conference Call February 1, 2024 4:30 PM ET Company Participants Ryan Simon - Vice President, Investor Relations Steve MacMillan - Chairman, President and Chief Executive Officer Karleen Oberton - Chief...
Through a Combination of Advanced Imaging and Novel Artificial Intelligence, Latest Diagnostic System for Cervical Cancer Screening Can Help More Accurately Detect Disease, Improve Workflow and Enhance Patient Care Hologic, Inc. (Nasdaq: HOLX) announced today that its new GeniusȒ...
2024-02-01 16:02:29 ET More on Hologic Hologic: Navigating The Covid Cliff Hologic, Inc. (HOLX) Q4 2023 Earnings Call Transcript Hologic Q1 2024 Earnings Preview Hologic guides Q1 revenue above estimates Seeking Alpha’s Quant Rating on Hologic ...
News, Short Squeeze, Breakout and More Instantly...
– Revenue of $1,017.8 Million, GAAP Diluted EPS of $0.72, and Non-GAAP Diluted EPS of $1.03; Revenue and Non-GAAP Diluted EPS Exceeded Guidance – – Total Company Organic Revenue Growth Excluding COVID-19 of 4.9% in Constant Currency; Against a 21.9% Prior Year Period Comp...
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced that it signed a definitive agreement to acquire Endomagnetics Ltd (Endomag®), a privately held developer of breast cancer surgery technologies, for approximately $310 million, subject to working capital ...